Anticorps Recombinant de lapin anti-B7-H4

B7-H4 Recombinant Antibody for FC

Hôte / Isotype

Lapin / IgG

Réactivité testée

rat

Applications

FC

Conjugaison

Non conjugué

CloneNo.

250392E12

N° de cat : 98552-2-RR

Synonymes

B7H4, B7S1, B7x, V-set domain-containing T-cell activation inhibitor 1, Vtcn1



Applications testées

Résultats positifs en cytométrieTransfected HEK-293T cells,

Dilution recommandée

ApplicationDilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

98552-2-RR cible B7-H4 dans les applications de FC et montre une réactivité avec des échantillons rat

Réactivité rat
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène B7-H4 Protéine recombinante Eg3230
Nom complet V-set domain containing T cell activation inhibitor 1
Masse moléculaire calculée31 kDa
Numéro d’acquisition GenBankNM_001024244.1
Symbole du gène Vtcn1
Identification du gène (NCBI) 295322
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 0.09% sodium azide
Conditions de stockageStore at 2 - 8°C. Stable for one year after shipment.

Informations générales

B7-H4, also named VTCN1, B7X, or B7S1, is a single-pass type I membrane protein, which contains two immunoglobulin-like domains and belongs to the immunoglobulin superfamily. B7-H4 negatively regulates T-cell mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. B7-H4 is over-expressed in many cancers, including breast, ovarian, endometrial, renal cell and non-small-cell lung cancers.

Protocole

Product Specific Protocols
FC protocol for B7-H4 antibody 98552-2-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}